Clinical Trial Update: Product Design Clinical Performance Study of sc2Wear Furosemide Combination Product [Phase 3]

View source ↗

Summary

The Phase 3 Product Design Clinical Performance Study of the sc2Wear Furosemide Combination Product for heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• sc2Wear Furosemide Combination Product (furosemide)

Snippet

Sponsor: scPharmaceuticals, Inc. | Conditions: Heart Failure | Phase 3 | Status: COMPLETED